Full results from two Lilly trials of the novel triple hormone receptor agonist show reductions in A1c, osteoarthritis knee pain, and obstructive sleep apnea.

More nurses regularly take on second shifts but as the practice becomes normalized, is this best for patients?

Phase 3 data on sunvozertinib for EGFR exon 20 insertions and sacituzumab tirumotecan plus pembrolizumab for PD-L1-positive ...

A pilot study shows that a urine-based metabolite panel accurately distinguishes children with autism from typically ...

The first known analysis of pooled worldwide population-based data on dementia with Lewy bodies shows incidence is higher ...

Both T1D and T2D are linked to a higher incidence of subtrochanteric or femoral shaft and hip fractures, but after adjusting ...

New research suggests that time and aging change how people deal with regrets. Here’s what it could mean for doctors.

Weekly subcutaneous injections of the novel B-cell inhibitor obexelimab significantly reduces disease flares and lowers toxic ...

In men, high adolescent cardiorespiratory fitness is linked to a small excess risk for atrial fibrillation in early adulthood ...

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical ...

An intramuscular Masson tumor in the deltoid muscle mimics a malignant vascular tumor on imaging, making surgical excision ...

A new study in mice finds that cannabis extracts improve glucose regulation by improving communication between fat cells and ...